Biotechnology companies have repeatedly turned to e-learning to reduce what they spend on training staff. The details of any single company’s rollout are not covered here. What follows is the confirmed picture of why the sector adopts these tools and what vendors and case studies report.
The problem: training that is costly and must be proven
Biotech firms train staff on standard operating procedures, laboratory practice and regulatory requirements, often across several sites. An LMS standardises how that training is delivered and tracked. It lets trainers give consistent training to every employee, whatever their location, which suits firms with global operations or distributed labs.
Classroom delivery adds recurring costs. Digitising and centralising training reduces reliance on time-consuming classroom sessions and lowers costs such as travel and instructor fees, while also minimising downtime. That analysis comes from IntuitionLabs’ comparison of training systems for life sciences companies.
How e-learning answered it
Compliance is a second driver alongside cost. Vendors such as UL Solutions pitch their systems as a way for pharmaceutical, medical device and biologics companies to meet personnel training requirements. UL Solutions says an LMS can help companies comply with the US FDA and other regulators, including the requirements of 21 CFR Part 11.
MasterControl markets training software on similar grounds. It describes a web-based system that automates personnel and employee training processes to meet FDA GMP requirements, citing 21 CFR Part 211.25.
Audit readiness and onboarding are cited as further gains. LMS software automates compliance-related training and logs, which reduces the effort of preparing for FDA, ISO or EMA audits. New hires can also reach mandatory GxP and company-specific training from their first day, which shortens the time to productivity. Both claims come from the findlmsoftware guide to biotech LMS products.
What the savings looked like
Savings figures come from vendors and should be read as such. TransPerfect Life Sciences, which sells the TI GlobalLearn LMS, says centralising training management can help pharma companies launch content faster while cutting costs by up to 40%.
Ozemio published a case study of a Germany-based life sciences company that replaced recurring facilitator-led sessions on material master data management. The company began work with Ozemio in June 2024. The programme ran over 10 months. Ozemio reported that the simulation-based training reduced costs by 35% for the customer. The company is not named, and the figure comes from the vendor, not an independent audit.
Limits of the approach
Online training has an up-front cost. A Scribd-hosted document on e-training notes that developing courses requires a substantial initial financial investment. It also says that a blended approach combining online and in-person training is gaining popularity. That document is a general overview, not a biotech study.
The sector’s use of these tools has since widened. Companies working in pharmaceutical R&D, medical devices, diagnostics and CRISPR development are using LMS tools to trace work and keep their workforce competent.